SPECIES-DIFFERENCES IN URINARY BUTADIENE METABOLITES - COMPARISONS OF METABOLITE RATIOS BETWEEN MICE, RATS, AND HUMANS

被引:100
作者
BECHTOLD, WE [1 ]
STRUNK, MR [1 ]
CHANG, IY [1 ]
WARD, JB [1 ]
HENDERSON, RF [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PREVENT MED & COMMUNITY HLTH,GALVESTON,TX 77555
关键词
D O I
10.1006/taap.1994.1137
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have previously identified two metabolites, 1,2-dihydroxy-4-(N-acetylcysteinyl-S-)-butane (M-I) and 1-hydroxy-2-(N-acetylcysteinyl-S-)-3-butene (M-II) in the urine of mice, rats, hamsters, and monkeys exposed by inhalation to 8000 ppm [C-14]butadiene. The sum of these two metabolites constituted between 50 and 90% of the total urinary [C-14]butadiene equivalents. When comparing species, the ratios of excreted M-I relative to the total of M-I + M-II were linearly related to hepatic epoxide hydrolase activities, with mice displaying the lowest ratios and monkeys displaying the highest ratios. Because humans are known to have epoxide hydrolase activities more similar to those of monkeys than mice, we postulated that after inhalation of butadiene, humans would excrete predominantly M-I and little M-II. To address this hypothesis, we measured the two metabolites in the urine of workers occupationally exposed to butadiene. We initially developed an assay to measure the two metabolites in urine using techniques not dependent on radiolabeled compounds. The assay is based on isotope-dilution gas chromatography/mass spectroscopy. After addition of deuterated internal standards, the metabolites were isolated from urine samples by solid-phase extraction and selective precipitation. The metabolites were converted to volatile derivatives by trimethylsilylation prior to analysis. The assay is sensitive down to at least 100 ng/ml of both metabolites in urine. The assay was applied to urine samples of humans occupationally exposed to butadiene in a production plant. M-I, but not M-II, could be readily identified and quantitated in the urine samples at levels frequently greater than 1 mu g/ml, thus supporting our hypothesis. Employees who worked in production areas with historical atmospheric concentrations of 3-4 ppm butadiene could be distinguished as a group from those outside controls. Finally, mice and rats were exposed to 11.7 ppm butadiene for 4 hr, and the ratio of the two metabolites was measured. For mice, the ratios of M-I to M-I + M-II were similar to those reported previously following exposure to 8000 ppm. In contrast, for rats, M-I represented a higher proportion of the excreted metabolites at the lower exposure level. These results confirm earlier in vitro studies that suggested the predominant pathway for clearance of BDO in humans is by hydrolysis rather than direct conjugation with glutathione. (C) 1994 Academic Press, Inc.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 14 条
  • [1] SPECIES-DIFFERENCES IN THE DISPOSITION OF INHALED BUTADIENE
    BOND, JA
    DAHL, AR
    HENDERSON, RF
    DUTCHER, JS
    MAUDERLY, JL
    BIRNBAUM, LS
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 84 (03) : 617 - 627
  • [2] ANALYSIS OF 1,3-BUTADIENE AND OTHER SELECTED GAS-PHASE COMPONENTS IN CIGARETTE MAINSTREAM AND SIDESTREAM SMOKE BY GAS-CHROMATOGRAPHY MASS SELECTIVE DETECTION
    BRUNNEMANN, KD
    KAGAN, MR
    COX, JE
    HOFFMANN, D
    [J]. CARCINOGENESIS, 1990, 11 (10) : 1863 - 1868
  • [3] COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE
    CSANADY, GA
    GUENGERICH, FP
    BOND, JA
    [J]. CARCINOGENESIS, 1992, 13 (07) : 1143 - 1153
  • [4] TOXICOKINETICS OF INHALED 1,3-BUTADIENE IN MONKEYS - COMPARISON TO TOXICOKINETICS IN RATS AND MICE
    DAHL, AR
    SUN, JD
    BIRNBAUM, LS
    BOND, JA
    GRIFFITH, WC
    MAUDERLY, JL
    MUGGENBURG, BA
    SABOURIN, PJ
    HENDERSON, RF
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 110 (01) : 9 - 19
  • [5] MULTIPLE ORGAN CARCINOGENICITY OF 1,3-BUTADIENE IN B6C3F1 MICE AFTER 60 WEEKS OF INHALATION EXPOSURE
    HUFF, JE
    MELNICK, RL
    SOLLEVELD, HA
    HASEMAN, JK
    POWERS, M
    MILLER, RA
    [J]. SCIENCE, 1985, 227 (4686) : 548 - 549
  • [6] SYMPOSIUM OVERVIEW - TOXICOLOGY, CARCINOGENESIS, AND HUMAN HEALTH-ASPECTS OF 1,3-BUTADIENE
    MELNICK, RL
    HUFF, JE
    BIRD, MG
    ACQUAVELLA, JF
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 86 : 3 - 5
  • [7] ISOLATION OF POLYCYCLIC ORGANIC-COMPOUNDS BY SOLVENT-EXTRACTION WITH DIMETHYL-SULFOXIDE
    NATUSCH, DFS
    TOMKINS, BA
    [J]. ANALYTICAL CHEMISTRY, 1978, 50 (11) : 1429 - 1434
  • [8] NELIGAN RE, 1962, ARCH ENVIRON HEALTH, V5, P67
  • [9] HEMOGLOBIN ADDUCTS AND URINARY MERCAPTURIC ACIDS IN RATS AS BIOLOGICAL INDICATORS OF BUTADIENE EXPOSURE
    OSTERMANGOLKAR, S
    KAUTIAINEN, A
    BERGMARK, E
    HAKANSSON, K
    MAKIPAAKKANEN, J
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1991, 80 (03) : 291 - 302
  • [10] INHALATION TOXICITY STUDIES WITH 1,3-BUTADIENE - 3 2 YEAR TOXICITY CARCINOGENICITY STUDY IN RATS
    OWEN, PE
    GLAISTER, JR
    GAUNT, IE
    PULLINGER, DH
    [J]. AMERICAN INDUSTRIAL HYGIENE ASSOCIATION JOURNAL, 1987, 48 (05): : 407 - 413